PharmaStrategies > Market Expansion

The Brand Advantaged Program increases the number of patients utilizing your product by providing access to those who otherwise might not be able to afford it. This significantly expands the patient pool by expanding the market of insured patients who can afford their co-pay.
 
The Life Cycle Extension Program uses similar market forces to eliminate the only advantage generic drugs have over your Branded product.
 
Pharmaceutical products are primarily marketed to the same end user, the consumer representing the ~65% of the population who have a Pharmaceutical benefit and can afford their co-pay. That overlooks the ~30% of the population who have a Pharmaceutical benefit but cannot afford their co-pay. The PharmaStrategies Programs expand the current market to include a substantial portion of those who otherwise could not afford their co-pay.